AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Switglim-M 1/1000 Tablet PR

Prescription Icon
Prescription Required

Marketer

Akumentis Healthcare Ltd

Salt Composition

Glimepiride (1mg) + Metformin (1000mg)

Overview Switglim-M 1/1000 Tablet PR

Diabexe Duo 1/1000 Tablet is an antidiabetic medication, a dual-action formulation for adult type 2 diabetes management. It effectively regulates blood glucose levels. Diabexe Duo should be ingested with meals, consistently at the same time daily for optimal results. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical guidance can lead to elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (like sugary snacks or juice) are essential for prevention. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your doctor before use if pregnant or breastfeeding. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are necessary.

Uses of Switglim-M 1/1000 Tablet PR

Managing type 2 diabetes

Major Benefits of Switglim-M 1/1000 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for dosage guidance. Administer Switglim-M 1/1000 Tablet PR with a meal.

Common Side effects of Switglim-M 1/1000 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Switglim-M 1/1000 Tablet PR:

Follow your doctor's instructions or consult the product label for proper usage. Consume Switglim-M 1/1000 Tablet PR with a meal.

How Switglim-M 1/1000 Tablet PR works:

Switglim-M 1/1000 PR tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Switglim-M 1/1000 Tablet PR and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Switglim-M 1/1000 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should not use Switglim-M 1/1000 Tablet PR. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Switglim-M 1/1000 Tablet PR cautiously, potentially requiring dosage modification. Physician consultation is advised. Switglim-M 1/1000 Tablet PR is contraindicated in those with severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Switglim-M 1/1000 Tablet PR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate hepatic dysfunction, initiation at a reduced dosage is typical; however, it's contraindicated in patients with severe liver disease.

What if you forget to take Switglim-M 1/1000 Tablet PR :

Should you forget to take a Switglim-M 1/1000 Tablet PR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Switglim-M 1/1000 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Switglim-M 1/1000 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Switglim-M 1/1000 Tablet PR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare but dangerous side effect is particularly risky for individuals with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Switglim-M 1/1000 Tablet PR and seek immediate medical attention.
Switglim-M 1/1000 Tablet PR combines glimepiride and metformin to treat type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Switglim-M 1/1000 Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged Switglim-M 1/1000 Tablet PR use can induce Vitamin B12 deficiency by hindering its stomach absorption. This may lead to anemia, neurological issues (including tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Switglim-M 1/1000 Tablet PR can indeed cause hypoglycemia (low blood sugar). Symptoms may include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Switglim-M 1/1000 Tablet PR and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Switglim-M 1/1000 Tablet ...
66
MRP 77
14% off